NYU Langone Health
Open enrollment with an early-phase pipeline tilt
According to ClinicalTrials.gov-derived indexes, NYU Langone Health sits in the top decile of US sponsors by registered trial count (#25 of 15,742 sponsors by registered trial count).
NYU Langone Health: 1,164 sponsored US clinical trials, 197 recruiting.
NYU Langone Health sponsors 1,164 registered US clinical trials on ClinicalTrials.gov, 197 of them currently recruiting, and 741 completed. 123 of these trials are in Phase 3-4 (later-stage) and 231 in Phase 1-2 (earlier-stage). The most-studied condition in this pipeline is Prostate Cancer, with 12 trials.
Top-decile sponsor footprint
NYU Langone Health ranks in the top decile of sponsors by registered trial count (#25 of 15,742 sponsors by registered trial count). Volume at this scale usually reflects a long institutional pipeline, read phase tilt and therapeutic areas below before treating it as current-year activity.
Trial completion reliability score
741 of 866 decided trials (Completed vs. Terminated on ClinicalTrials.gov) reached their planned completion (85.6%), vs. national p10 68.4% / p90 100% among 1,234 sponsors with at least 10 decided trials. Still-open trials (Recruiting, Active-not-recruiting, Not-yet-recruiting) are excluded since they have not reached an outcome yet.
Open and recent trials
1,164 total, page 4 of 24
Autoimmune and Autoinflammatory Genetics Study
NCT06004349
Influence of Social Media Ads on Food Choice - Master Protocol
NCT07249398
NIH RECOVER Tissue Pathology: Understanding the Long-Term Impact of COVID-19
NCT05292274
Multi-Center PAMPA Study
NCT05004727
Aβ Dynamics in LLMD
NCT05004987
MBSR Mechanisms in GAD
NCT05064813
Telephone-Based Support Programs for People With Epilepsy
NCT05082181
Smartphones for Opiate Addiction Recovery
NCT05033028
Blood Flow Restriction Therapy in Achilles Injury
NCT04104126
Effects of Contralateral Strength Training on Postoperative Strength Deficits in the Immobilized Lower Extremity
NCT03650374
Blood Flow Restriction Therapy in Lower Limb Extensor Injuries
NCT04149977
Verbal Working Memory and Attention Remediation for Adults With Traumatic Brain Injury.
NCT04349852
A Multi-Phase Study Examining Hospital to Home Transitions for Children With Medical Complexity
NCT04867395
Oral Nutritional Optimization in Total Joint Arthroplasty
NCT04210284
Cannabidiol as a Treatment for PTSD and PTSD Comorbid With TBI
NCT04550377
ROSE in Sunset Park
NCT04940585
Supporting Safe Use of Medications by Parents After Infant Discharge From the Neonatal Intensive Care Unit
NCT04278690
Longitudinal Evaluation of Microbial and Host Signatures During Immunotherapy for Lung Cancer
NCT04063501
Bridging the Evidence-to-practice Gap
NCT03713515
Belatacept in De Novo Heart Transplantation
NCT04477629
Surveillance and Treatment to Prevent Fetal Atrioventricular Block Likely to Occur Quickly (STOP BLOQ)
NCT04474223
COVID-19 Survivorship Registry
NCT04527315
Heart Attack Research Program: Platelet Sub-Study (HARP)
NCT03022552
The Effect of Yoga Practice on Chronic Back Pain
NCT04270617
Leveraging Biomarkers for Personalized Treatment of Alcohol Use Disorder Comorbid With PTSD
NCT03667846
Craniomaxillofacial and Upper Extremity Allotransplantation
NCT04057638
Using tDCS in Speech-based Stroke Rehabilitation
NCT03452202
Investigating Auditory Processing in the Users of Auditory Brainstem and Cochlear Implants
NCT05810220
Novel Coding Strategies for Children With Cochlear Implants
NCT05203302
IOP Elevation Study
NCT03400137
Adaptive Treatment De-escalation in Favorable Risk HPV-Positive Oropharyngeal Carcinoma
NCT03215719
Modulating Movement Intention Via Cortical Stimulation
NCT03233399
Prospective Database of Clinical Outcomes Following Cryotherapy for Ablation of Clinically Localized Prostate Cancer
NCT07184957
The Natural History of Familial Dysautonomia
NCT03920774
Women's Heart Attack Research Program: Stress Ancillary Study
NCT02914483
Food and Microbiome Longitudinal Investigation (FAMiLI)
NCT03293758
Hand Transplantation
NCT02476838
Evaluation Of The Lung Microbiome In NTM Bronchiectasis
NCT02779478
Sudden Unexplained Death in Childhood (SUDC) Registry
NCT03109197
Auditory Brainstem Implant (ABI) in Children With No Cochleae or Auditory Nerves
NCT02310399
Lung Microbiome and Inflammation in Early COPD
NCT02777879
Natural History Study of Synucleinopathies
NCT01799915
Risk Factors for Sudden Unexplained Death in Epilepsy
NCT01662453
Registry of Patients With Takotsubo Syndrome
NCT03663348
NYU/Bellevue WTC Health Impacts Research Registry
NCT00404898
Hirschsprung Disease Genetic Study
NCT00478712
Lung Cancer Biomarkers and Screening
NCT00301119
HIV Antibody Increases Following Viral Rebound in People Receiving Antiretroviral Therapy
NCT07665060
ED-LEAD: Emergency Departments Leading the Transformation of Alzheimer's and Dementia Care
NCT06079203
A Community-based Educational Initiative to Raise Awareness of Melanoma and Other Skin Cancers.
NCT07177638
Phase Distribution
| Phase | Trial count |
|---|---|
| Phase 1 | 99 |
| Phase 2 | 132 |
| Phase 3 | 28 |
| Phase 4 | 95 |
Therapeutic Areas
What is open in the NYU Langone Health pipeline
197 recruiting of 1,164 indexed (17% open); 741 completed (64%).
Phase mix: 123 late (III/IV) vs 231 early (I/II) (early-phase heavy).
Top condition: Prostate Cancer (12 trials), 9 others listed.
How open-pipeline share is computed
Recruiting share is recruiting_count divided by trial_count for this sponsor in the public registry export. Status can change between pulls; treat the figure as a research-attention snapshot, not product availability.
NYU Langone Health: open-pipeline peers nationwide
Peers matched on 1,164 registered trials and 17% open enrollment, not the therapeutic-area sidebar.
NYU Langone Health sits at or above the median trial volume and at or above the median recruiting share among these 9 nationwide peers -- the two do not always move together.
Sponsors near 1,164 trials (± recruiting share)
- University of Alabama at Birmingham · 1,160 trials · 19% recruiting
- Wake Forest University Health Sciences · 1,140 trials · 15% recruiting
- Emory University · 1,208 trials · 17% recruiting
- Northwestern University · 1,209 trials · 15% recruiting
Sponsors near 17% open enrollment (± trial volume)
- CSL Behring · 17% recruiting · 71 trials
- Penn State University · 17% recruiting · 219 trials
- University of Hawaii · 17% recruiting · 77 trials
- University of Utah · 17% recruiting · 818 trials
Related
What to do with this NYU Langone Health page
1,164 registered trials is a research-attention snapshot, not an endorsement of NYU Langone Health or any single study.
- 197 of NYU Langone Health's trials are currently recruiting, check each one's own eligibility criteria before contacting a site. Browse recruiting trials
- Prostate Cancer is the condition NYU Langone Health studies most, compare against other sponsors active in the same condition before evaluating a specific study. See Prostate Cancer trials
- Bring the specific trial ID (NCT number) to your own doctor before enrolling, this page is a directory, not medical guidance. Read the trial-finding guide
Trial and recruiting counts reflect ClinicalTrials.gov registry status as of the data vintage above; individual trial eligibility and enrollment status can change.
NYU Langone Health pipeline card: 1,164 registered trials from official public datasets.Report a data error.